Maria Santoro
Maria Santoro
Research fellow, Tor Vergata University
Verifierad e-postadress på
Citeras av
Citeras av
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study
The Lancet Infectious Diseases 16 (5), 565-575, 2016
HIV-1 genetic variability and clinical implications
MM Santoro, CF Perno
International Scholarly Research Notices 2013, 2013
Comet assay and micronucleus test in circulating erythrocytes of Cyprinus carpio specimens exposed in situ to lake waters treated with disinfectants for potabilization
A Buschini, A Martino, B Gustavino, M Monfrinotti, P Poli, C Rossi, ...
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 557 (2 …, 2004
Antiretroviral therapy in prevention of HIV and TB: update on current research efforts.
HG Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, Simao M ...
Curr HIV Res 9 (6), 446-69, 2011
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors
V Svicher, T Sing, MM Santoro, F Forbici, F Rodríguez-Barrios, A Bertoli, ...
Journal of virology 80 (14), 7186-7198, 2006
Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to …
F Ceccherini-Silberstein, V Svicher, T Sing, A Artese, MM Santoro, ...
Journal of virology 81 (20), 11507-11519, 2007
Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors
V Svicher, F Ceccherini-Silberstein, F Erba, M Santoro, C Gori, ...
Antimicrobial agents and chemotherapy 49 (5), 2015-2025, 2005
Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels
MM Santoro, L Fabeni, D Armenia, C Alteri, D Di Pinto, F Forbici, A Bertoli, ...
Clinical infectious diseases 58 (8), 1156-1164, 2014
High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations
F Ceccherini-Silberstein, F Gago, M Santoro, C Gori, V Svicher, ...
Journal of virology 79 (16), 10718-10729, 2005
Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy
G Zehender, E Ebranati, A Lai, MM Santoro, C Alteri, M Giuliani, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 156-160, 2010
Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon
J Fokam, R Salpini, MM Santoro, V Cento, CF Perno, V Colizzi, ...
The Pediatric infectious disease journal 30 (12), 1062-1068, 2011
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens
V Svicher, C Alteri, A Artese, F Forbici, MM Santoro, D Schols, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (3), 336-344, 2010
Specific Enfuvirtide-Associated Mutational Pathways in HIV-1 Gp41 Are Significantly Correlated With an Increase in CD4+ Cell Count, Despite Virological Failure
S Valentina, S Aquaro, R D'Arrigo, A Artese, S Dimonte, S Alcaro, ...
The Journal of infectious diseases 197 (10), 1408-1418, 2008
Characterization of drug resistance mutations in naīve and ART‐treated patients infected with HIV‐1 in Yaounde, Cameroon
L Ceccarelli, R Salpini, S Moudourou, V Cento, MM Santoro, J Fokam, ...
Journal of medical virology 84 (5), 721-727, 2012
The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries
M Salemi, MM Goodenow, S Montieri, T de Oliveira, MM Santoro, ...
AIDS research and human retroviruses 24 (6), 771-779, 2008
Impact of pre-therapy viral load on virological response to modern first-line HAART
MM Santoro, D Armenia, C Alteri, P Flandre, A Calcagno, C Gori, L Fabeni, ...
International Medical Press 18 (7), 867-876, 2013
Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon
J Fokam, R Salpini, MM Santoro, V Cento, R D’Arrigo, C Gori, CF Perno, ...
Archives of virology 156 (7), 1235-1243, 2011
Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: an international collaboration
SY Rhee, V Varghese, SP Holmes, GU Van Zyl, K Steegen, MA Boyd, ...
EBioMedicine 18, 225-235, 2017
Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA
M Zaccarelli, MM Santoro, D Armenia, V Borghi, W Gennari, C Gori, ...
Journal of Clinical Virology 82, 94-100, 2016
Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir+ emtricitabine/lamivudine+ efavirenz …
JL Blanco, JSG Montaner, VC Marconi, MM Santoro, AE Campos-Loza, ...
Aids 28 (17), 2531-2539, 2014
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20